James Lancaster

James Lancaster
James Y. Lancaster, Managing Director VIC Texas Branch, CEO of Tesseract Structural Innovations and CEO of Solenic Medical Inc, is a versatile and innovative technology executive and with over 25 years of experience across multiple industries. Mr. Lancaster holds a BBA from Texas A&M and an MBA from the University of Texas at Austin.
Find me on:

Recent Posts

Tesseract Structural Innovations Receives Two New US and WO Patents

The patents extend Tesseract’s automotive crash energy absorption platform to save lives. The company has received a Notice of Granting and Publication of its second patent “Uniform Deceleration Unit” June 1, 2021 by...

Solenic Medical Wins Big at the 2021 Texas A&M New Ventures Competition

Solenic Medical participated in the 2021 Texas A&M New Ventures Competition (TNVC) held live at Texas A&M University after being held virtually in 2020. Twenty-one companies were invited to participate May 19-20 for...

From the Corner Office: Solenic Medical Reaches a Two-Year Anniversary Milestone

The two-year anniversary point in any startup provides an opportunity to reflect on the surprises and unexpected turns in the road, many of which could not have been predicted. Solenic Medical’s second year was unlike...

The Anatomy of a Friends and Family Round in a COVID-19 World

When I wrote about fundraising early this year, I knew that I would be raising a round shortly, but had no idea I would be doing it in a changed COVID-19 world. I have experienced two unexpected recessions as an...

Solenic Medical Receives FDA Breakthrough Device Designation

TEXAS – July 29, 2020 – Solenic Medical, a developer of a device that uses alternating magnetic fields to treat a prosthetic joint infections (PJI) announced today that it has received Breakthrough Device designation...

Enjoy The Ride: Inside an Automotive Startup

Startups are known to be roller coaster rides, but what do you get when you launch an automotive industry startup? A really wild ride! The past year or so has indeed been a wild ride since I took over as CEO of...

Failing to fundraise can be the downfall of startups

Startups are pulling outsized financing rounds and debt acquisitions at an unprecedented rate despite the high 80 percent failure rate of startups overall. Among the three primary reasons why startups tend to fail,...

Houston Innovation Map: 3 Houston Innovators to Know This Week

James Y. Lancaster, Texas Branch Manager Of VIC Technology Venture Development Takes University-Founded Research Innovations To The Marketplace. An Arkansas-based technology venture development firm had its eyes on...

VIC Highlighted by Houston Innovation Map

Exclusive: Out-Of-State Venture Firm Specializing In Research-Based Startups Expands Into Houston. For an Arkansas-based technology venture development firm that focuses on research-based companies coming out of...


VIC Tech Announces New Class of Fellows
Our Life Science and Healthcare Future
White Paper
Portfolio Diversification in Times of Market Volatility
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
Solenic Medical, Inc. Announces $5.1M Series A Funding Round Led by Johnson & Johnson Innovation – JJDC, Inc.
VIC Fellows Spotlight: Matthew Leming, PhD
From The Corner Office
From the Corner Office: Michael Artinger, PhD – CEO of Solaris Vaccines, Inc.